Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
21.3M
-
Shares change
-
-7M
-
Total reported value, excl. options
-
$17.7M
-
Value change
-
-$5.65M
-
Put/Call ratio
-
7.45
-
Number of buys
-
42
-
Number of sells
-
-50
-
Price
-
$0.83
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2025
115 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q2 2025.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.3M shares
of 129M outstanding shares and own 16.51% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.83M shares), AMERIPRISE FINANCIAL INC (2.97M shares), BlackRock, Inc. (2.15M shares), MILLENNIUM MANAGEMENT LLC (2.05M shares), RENAISSANCE TECHNOLOGIES LLC (1.81M shares), GEODE CAPITAL MANAGEMENT, LLC (1.3M shares), STATE STREET CORP (517K shares), JANE STREET GROUP, LLC (459K shares), Qube Research & Technologies Ltd (416K shares), and UBS Group AG (412K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.